Knockdown of PRR14 inhibits the growth and migration of gastric cancer cells

Background: Although proline-rich protein (PRR) 14 has been implicated in various malignancies, its involvement in stomach cancer is yet unclear. In order to improve therapeutic approaches for gastric cancer, this study intends to explore the ways in which PRR14 controls the growth and metastasis of gastric cancer cells. Methods: PRR14 expression levels in gastric cancer were analyzed using the The University of Alabama at Birmingham CANcer data analysis Portal (UALCAN) database, while the Kaplan-Meier Plotter database was used to evaluate the impact of PRR14 expression on overall survival in gastric cancer patients. After PRR14 knockdown, cell proliferation was evaluated using colony formation and cell counting kit-8 (CCK8) assays. Using flow cytometry, the rates of cell apoptosis were determined. Cell migration and invasion were assessed using transwell and wound healing assays. Protein expression in the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway was evaluated by Western blotting. Results: Significant expression of PRR14 was discovered in stomach cancer tissues, and it was associated with poor prognosis. Knockdown of PRR14 significantly reduced cell viability, colony formation, migration and invasion, while promoting apoptosis in gastric cancer cells. Furthermore, the expression levels of p-PI3K and p-Akt were markedly decreased following PRR14 knockdown. Conclusions: PRR14 knockdown inhibits the proliferation, migration and invasion of gastric cancer cells while promoting apoptosis, possibly via blocking the PI3K/Akt signaling pathway. According to these results, PRR14 might be a viable target for treatment in gastric cancer.

Gastric cancer; PRR14; Proliferation; Migration; PI3K/Akt

[1] Wang X, Liu Y, Zhao Q, Wang X, Chen X, Hou L, et al. PILRB potentiates the PI3K/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis. Cell Death & Disease. 2024; 15: 642.

[2] Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. Journal of Hematology & Oncology. 2023; 16: 57.

[3] Guo Q, Xu J, Huang Z, Yao Q, Chen F, Liu H, et al. ADMA mediates gastric cancer cell migration and invasion via Wnt/β-catenin signaling pathway. Clinical and Translational Oncology. 2021; 23: 325–334.

[4] Dunlevy KL, Medvedeva V, Wilson JE, Hoque M, Pellegrin T, Maynard A, et al. The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting. Journal of Cell Science. 2020; 133: jcs240416.

[5] Zhang L, Yang J, Ji Z, Zhang J, Yang S. PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma. Journal of Cancer. 2023; 14: 1531–1540.

[6] Yang M, Lewinska M, Fan X, Zhu J, Yuan ZM. PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis. Oncogene. 2016; 35: 5527–5538.

[7] Cheng L, Li X, Dong W, Yang J, Li P, Qiang X, et al. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway. Journal of Cancer Research and Clinical Oncology. 2024; 150: 230.

[8] Wu L, Yu M, Liang H, Lin L, Li H, Chen G, et al. SJB2-043, a USP1 inhibitor, suppresses A549 cell proliferation, migration, and EMT via modulation of PI3K/AKT/mTOR, MAPK, and Wnt signaling pathways. Current Issues in Molecular Biology. 2025; 47: 155.

[9] Hu M, Tao P, Wang Y, Zhu C, Ma Y, Liu X, et al. Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway. Scientific Reports. 2025; 15: 5703.

[10] Li F, Zhang C, Fu L. PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway. PLOS ONE. 2019; 14: e0218839.

[11] Chen J, Ji Z, Wu D, Wei S, Zhu W, Peng G, et al. MYBL2 promotes cell proliferation and inhibits cell apoptosis via PI3K/AKT and BCL2/BAX/cleaved-caspase-3 signaling pathway in gastric cancer cells. Scientific Reports. 2025; 15: 9148.

[12] Ren X, Long M, Li Z, Wu B, Jin T, Tu C, et al. Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway. Cell Death & Disease. 2020; 11: 464.